Dr. Reddy's (DRREDDY) | Stock Overview & Key Data
Dr. Reddy's Performance Comparison
Stock Range
Today's Range
Low: ₹1,195.50
High: ₹1,215.00
on August 8, 2025
52 Week Range
Low: ₹1,020.00
High: ₹1,421.49
on April 7, 2025
on August 21, 2024
All-Time High: ₹1,421.49 on August 19, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR999.8B
EPS
68.09
P/E Ratio (TTM)
17.64
Forward P/E
3.50
P/B Ratio
2.86
PEG Ratio
3.50
Div. Yield
11.59%
ROE
17.71%
Beta
0.311
Debt to Equity
13.75
Financial Highlights
Profitability
Gross Margin
56.91%
Operating Margin
20.50%
Profit Margin
16.99%
Returns and Earnings
Return on Assets (TTM)
9.71%
Return on Equity (TTM)
17.71%
EBITDA
INR92.8B
Net Income (TTM)
INR56.8B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR401.75
Quarterly Revenue Growth (YoY)
11.40%
Quarterly Earnings Growth (YoY)
1.90%
Dividend Information
Last 12-Month Dividend
₹146.30
Current Dividend Yield
11.59%
3-Year Average Dividend Yield
3.74%
3-Year Average Annual Dividend
₹49.30
3-Year Total Dividends
₹147.90
Ex-Dividend Date
July 10, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Dr. Reddy's DRREDDY | 999.85B Large-cap | -5.47% | -8.37% | 3.45% | -3.19% | -12.29% | -14.39% | 40.91% | 32.85% |
| Sun Pharmaceutical SUNPHARMA | 3.92T Large-cap | -6.35% | -4.85% | -10.27% | -8.65% | -15.43% | -8.07% | 74.63% | 200.22% |
| Divi's Laboratories DIVISLAB | 1.63T Large-cap | -7.04% | -10.99% | -0.27% | -0.15% | 0.96% | 26.95% | 64.55% | 98.44% |
| Cipla CIPLA | 1.20T Large-cap | -4.09% | -1.29% | -1.18% | 1.27% | 0.78% | 3.58% | 45.16% | 93.18% |
| Torrent TORNTPHARM | 1.22T Large-cap | -3.88% | 7.29% | 9.29% | 10.38% | 5.21% | 5.56% | 128.85% | 24.13% |
| Mankind Pharma MANKIND | 1.08T Large-cap | -1.15% | 5.29% | 4.33% | 0.76% | -11.91% | 19.66% | 83.31% | 83.31% |
Ownership & Short Interest
Insider Ownership
29.46%
Institutional Ownership
49.87%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
2M
Average 90-Day Volume
1M
Dr. Reddy's Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Dr. Reddy's would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is DRREDDY's 52-week high and low?
- In the last 52 weeks, Dr. Reddy's reached a high of ₹1,421.49 (on August 21, 2024) and a low of ₹1,020.00 (on April 7, 2025).
- What is the market cap and P/E ratio for DRREDDY?
- Curious about Dr. Reddy's's size and valuation? Its market capitalization stands at 999.85B. When it comes to valuation, the P/E ratio (trailing twelve months) is 17.64, and the forward P/E (looking ahead) is 3.50.
- Does DRREDDY pay dividends? If so, what's the yield?
- Yes, Dr. Reddy's is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 11.59%, and the company has paid an average of ₹49.30 per share annually over the past 3 years.
- Who are Dr. Reddy's's main competitors or similar companies to consider before investing?
When looking at Dr. Reddy's, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.92T Healthcare Drug Manufacturers - Specialty & Generic -8.07% 74.63% Divi's Laboratories
DIVISLAB1.63T Healthcare Drug Manufacturers - Specialty & Generic 26.95% 64.55% Cipla
CIPLA1.20T Healthcare Drug Manufacturers - Specialty & Generic 3.58% 45.16% Torrent
TORNTPHARM1.22T Healthcare Drug Manufacturers - Specialty & Generic 5.56% 128.85% Mankind Pharma
MANKIND1.08T Healthcare Drug Manufacturers - Specialty & Generic 19.66% 83.31% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Dr. Reddy's Laboratories Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Dr. Reddy's's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 17.71%, the Debt to Equity ratio from the most recent quarter is 13.75, and its Gross Profit Margin stands at 56.91%.
- What is the recent revenue and earnings growth for DRREDDY?
- Looking at Dr. Reddy's's growth, its revenue over the trailing twelve months (TTM) was INR334B. Compared to the same quarter last year (YoY), quarterly revenue grew by 11.40%, and quarterly earnings saw a YoY growth of 1.90%.
- How much of DRREDDY stock is held by insiders and institutions?
- Wondering who owns Dr. Reddy's stock? Company insiders (like executives and directors) hold about 29.46% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 49.87%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.